Cita APA

Hsieh, Y., Chang, T., Su, W., Huang, C., Tsai, H., Chen, Y., . . . Wang, J. (2021). UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI. J Oncol.

Chicago Style Citation

Hsieh, Yi-Chien, et al. "UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated With First-Line Bevacizumab and FOLFIRI." J Oncol 2021.

Cita MLA

Hsieh, Yi-Chien, et al. "UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated With First-Line Bevacizumab and FOLFIRI." J Oncol 2021.